Company:  MAGENTA THERAPEUTICS, INC ... (MGTA)
Form Type:  4
Filing Date:  12/2/2019 
CIK:  0001690585 
Address:  100 TECHNOLOGY SQUARE
5TH FLOOR
 
City, State, Zip:  CAMBRIDGE, Massachusetts 02139 
Telephone:  857-201-2700 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$9.43  
Change: 
0.03 (0.32%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$372.34M
Trade MGTA now with 

© 2020  
Description of Business
We are a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients with autoimmune diseases, blood cancers and genetic diseases. Resetting the immune system through stem cell transplant is a well-established and often curative medical procedure involving a two-step process: (i) removing the disease-causing cells and (ii) replacing them with healthy cells to rebuild the immune system. As it exists today, stem cell transplant is a large market opportunity, but currently only approximately 40 percent of eligible patients receive a curative immune reset because of the risks and toxicities associated with the transplant procedure. New approaches are needed to extend immune reset to more patients, including drugs to: collect sufficient stem cells to rebuild a healthy immune system, remove disease-causing cells and prevent complications in rebuilding the new immune system.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES